Presenting author

Guy M. Goodwin

1 presentation

• W114. Durability of efficacy and safety of COMP360 psilocybin for treatment-resistant depression (TRD) across 26 weeks in a double-blind, randomized, controlled phase 3 study

  2026 ASCP Annual Meeting